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Introduction: Skin as the largest and easily accessible organ of the body represents an abundant source of adult
stem cells. Among them, dermal stem cells hold great promise in tissue repair and the skin granulation tissue has
been recently proposed as a promising source of dermal stem cells, but their biological characteristics have not
been well investigated.
Methods: The 5-bromo-2′-deoxyuridine (BrdU) lineage tracing approach was employed to chase dermal stem cells
in vivo. Granulation tissue derived cells (GTCs) were isolated and their in vitro proliferation, self-renewing, migration, and
multi-differentiation capabilities were assessed. Combined radiation and skin wound model was used to investigate the
therapeutic effects of GTCs. MicroRNA-21 (miR-21) antagomir was used to antagonize miR-21 expression. Reactive oxygen
species (ROS) were scavenged by N-acetyl cysteine (NAC).
Results: The quiescent dermal stem/progenitor cells were activated to proliferate upon injury and enriched in granulation
tissues. GTCs exhibited enhanced proliferation, colony formation and multi-differentiation capacities. Topical transplantation
of GTCs into the combined radiation and skin wound mice accelerated wound healing and reduced tissue fibrosis.
Blockade of the miR-21 expression in GTCs inhibited cell migration and differentiation, but promoted cell proliferation
and self-renewing at least partially via a ROS dependent pathway.
Conclusions: The granulation tissue may represent an alternative adult stem cell source in tissue replacement therapy and
miR-21 mediated ROS generation negatively regulates the stemness-related properties of granulation tissue derived cells.Introduction
Stem cell-based therapy has aroused great promise in re-
generative medicine and an adult stem cell source is a key
resource for clinical application. Skin, the largest organ of
the body, is emerging as a reservoir for adult stem cells.
Stem cells have been proven to exist in the epithelial layer
of the skin including epidermis [1-4] and appendages [5,6].
Recently, dermis – the stromal part of the skin – has been
demonstrated as a promising source of stem cell popula-
tions with high self-renewing and multilineage differenti-
ation capacities [7]. However, dermis-derived stem cells in
normal adults are relatively rare [8]. Very recently, granula-
tion tissue has been proposed as a potential source of* Correspondence: shicm@sina.com
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unless otherwise stated.dermal stem cells, and stem cells derived from the granula-
tion tissue could improve the recovery of kidney and liver
injury [9,10]. However, their biological characteristics were
poorly understood. It has been increasingly established that
stem cells play an important role in wound healing and
granulation tissue formation warrants proliferation and dif-
ferentiation of dermal stem cells. In this study, we identified
that dermal stem/progenitor cells were activated after
wounding by the 5-bromo-2′-deoxyuridine (BrdU) lineage
tracing approach. Granulation tissue-derived cells (GTCs)
were successfully isolated and exhibited enhanced prolifera-
tion, colony formation, and multidifferentiation capabilities
compared with nonwounded adult dermal cells. Topical
transplantation of the GTCs accelerated wound healing and
reduced tissue fibrosis in mice with combined radiation and
skin wound injury. Furthermore, microRNA (miR)-21 and
reactive oxygen species (ROS) were significantly upregulated
in these cells, and miR-21 was shown to promote cellhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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C57/BL mice were obtained from the Center of Experi-
mental Animal at the Third Military Medicine University
(TMMU, Chongqing, China). The experiments were con-
ducted in accordance with the Guidelines for the Care
and Use of Laboratory Animals of the TMMU, and all
procedures were approved by the Animal Care and Use
Committee of the TMMU.
Skin wound model
The skin wound model was performed as described previ-
ously [11]. In brief, mice were anesthetized with 1% pento-
barbital (30 mg/kg), and the back hair was shaved. Circular,
full-thickness skin excisions of 10 mm in diameter were
surgically made in the middle back of each animal.
Cell isolation and culture
For neonatal and adult dermal cell isolation, dorsal skin
was carefully dissected free of other tissue, cut into 1 to
2 mm3 pieces, and washed with phosphate-buffered saline
(PBS) three times. After being digested with 0.25% tryp-
sin–ethylenediamine tetraacetic acid (HyClone, Logan,
UT, USA) at 4°C overnight, the epidermis was removed,
and the remaining dermal parts were further digested with
0.25% collagenase I (Worthington, Biochemical Corpor-
ation, Lakewood, NJ, USA), and shaken at 37°C for an-
other 2 hours. The digested cells were then passed
through a 75 μm cell strainer (Sangon Biotech, Shanghai,
China), centrifuged, and resuspended in Iscove's Modified
Dulbecco's Media (HyClone), supplemented with 10%
fetal bovine serum (Gibco, Grand Island, NY, USA), 100
U/ml penicillin and 0.1 mg/ml streptomycin (all from
Beyotime, Shanghai, China). Cells were seeded in a tissue
culture flask at 1 × 103 cells/cm2, and maintained at 37°C
with 5% carbon dioxide. After 24 hours, the plates were
washed with PBS to remove residual nonadherent cells.
The remaining adherent cells were subcultured after ex-
posure to 0.25% trypsin–ethylenediamine tetraacetic acid
(HyClone) every 3 days. The cells of passage 2 or 3 were
used for further experiments. For GTC isolation, the granu-
lation tissues at 7 days after wounding were excised and cut
into 1 to 2 mm3 pieces, washed with PBS three times, then
digested with 0.25% collagenase I (Worthington, Biochem-
ical Corporation), and shaken at 37°C for 2 hours. Subse-
quently, they were processed in the same way as described
above to harvest the adherent cells. To antagonize the miR-
21 expression, cells were pretreated with miR-21 antagomir
(50 nM; Ribobio Co., Guangzhou, China) for 48 hours. For
scavenging the intracellular ROS, N-acetylcysteine (NAC,5 mM; Sigma, St. Louis, MO, USA) was added into the
culture medium or induced medium.
5-Bromo-2′-deoxyuridine pulse chase
BrdU (100 mg/kg; Sigma), a synthetic nucleoside analog of
thymidine, is able to be incorporated into dividing cells. To
measure the transient proliferation of the wound tissues,
BrdU was injected intraperitoneally 2 hours prior to tissue
harvest, and the nonwounded control skin or wounded tis-
sues (n = 3 mice per time point) were excised and fixed in
4% paraformaldehyde at 1, 3, 5, 7, 9, 12, and 15 days after
wounding. For label-retaining cell (LRC) detection, BrdU
was injected intraperitoneally six times with 12-hour inter-
vals into wounded mice (long-term BrdU labeling group)
or into the nonwounded mice (control group). To measure
the time of the transient-amplifying cells retaining the BrdU
label, BrdU was injected intraperitoneally once at 60 hours
after wounding (a single BrdU labeling group). On post-
wound days 3, 7, 9, 12, and 15, the wound tissues of the
three groups (n = 3 mice per time point for each group)
were excised and fixed in 4% paraformaldehyde. The signal
of BrdU was detected by immunohistochemistry. For
in vitro LRC detection, BrdU was injected intraperitoneally
six times with 12-hour intervals immediately after wound-
ing (n = 6 mice) or into the nonwounded mice (n = 6 mice).
The nonwounded dermal cells or GTCs at 7 days after
wounding were isolated and the adherent cells were
reseeded in a six-well plate at a density of 1 × 103 /well
(n = 6 wells per group) and cultured for another 8 days.
Subsequently, the cells were fixed in 4% paraformaldehyde,
and the colonies were counted. The signal of BrdU was
detected by immunofluorescence.
Combined radiation and skin wound model and GTC-
based treatment
The total body radiation injury (6 Gy) was made by a 60Co
γ-ray source. The absorption rate was 31.02 to 31.98 cGy/
minute. Mice were anesthetized with 1% pentobarbital
(30 mg/kg) after radiation, and the back hair was shaved.
Circular, full-thickness skin excisions of 8 mm in diameter
were surgically made in the middle back of each animal.
For treatment, 1 × 106 GTCs suspended in 200 μl PBS
were intradermally injected around each wound margin.
PBS (200 μl) without cells was used as the control. At in-
dicated time points, wounds (n = 6 in the transplantation
group or control group) were photographed and quanti-
fied by Image-J software (Rasband, W.S., ImageJ, U.S.
National Institutes of Health, Bethesda, Maryland, USA).
After the wound healed, the wound repair bed and sur-
rounding tissues were obtained. Paraffin sections were
stained by Sirius Red or immunostained with α-smooth
muscle actin antibody. The fibrotic tissue depths were
quantified in serial sections in the center of wounds
treated with GTCs or PBS.
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All procedures on these animals were approved by the Ani-
mal Care and Use Committee of the TMMU. All animal ex-
perimentation methodology was carried out in accordance
with the Guidelines for the Care and Use of Laboratory Ani-
mals of the TMMU and the Guidelines on Care and Use of
Laboratory Animals issued by the Chinese Council on Ani-
mal Research and the Guidelines of Animal Care.
Tissue staining
Immunohistochemistry was performed as described pre-
viously [11]. The rabbit anti-BrdU (1:200; Rockland,
Philadelphia, Pennsylvania, USA) was used and detected in
3,3′-diaminobenzidine. Slides were counterstained with
hematoxylin. The percentage of BrdU-positive cells was
calculated by counting the total number of basal cells of
granulation tissues and cells expressing nuclear BrdU stain.
Immunofluorescence was also performed as described
previously [12]. The rabbit anti-BrdU (1:200; Rockland) or
mouse monoclonal anti-α-smooth muscle actin antibody
(1:300; Sigma) was used and detected with secondary don-
key anti-mouse or rabbit IgG-Cy3 antibody (1:200; Beyo-
time). Cells were counterstained with the nuclear dye
4′,6-diamidino-2-phenylindole (Beyotime) and examined
with a fluorescence microscope.
Sirius red staining was performed as described previously
[11]. In brief, paraffin-embedded sections were dehydrated
and stained in Sirius red solution for 1 hour, then mounted
with Poly-Mount Xylene. Polaroid lens were used for im-
ages taken under a microscope.
Quantitative real-time PCR analysis of miR-21 expression
Total RNA was extracted using RNAiso Plus (TaKaRa,
Kyoto, Japan). For the miR-21 expression detection, stem-
loop RT-PCR was performed as described previously [13].
Quantitative PCR was carried out using a SYBR® Premix
Ex Taq™ II (Tli RNaseH Plus) real-time PCR kit (TaKaRa)
according to the manufacturer’s protocol. Relative expres-
sion was normalized to the expression of U6 small RNA.
The primers for miR-21 and U6 were purchased from
Ribobio Co. (Guangzhou, China). Three independent ex-
periments were performed. In each experiment, triplicate
procedures were performed for each group.
Measuring the endogenous ROS level
The ROS-sensitive dye 2′,7′-dichlorofluorescin diacetate
(10 mM; Beyotime) was used to measure the endogen-
ous cellular ROS level according to the manufacturer’s
protocol. In brief, the primary cells were incubated with
2′,7′-dichlorofluorescin diacetate for 20 minutes at 37°C
with reverse shaking every 3 to 5 minutes. The levels of
intracellular ROS were analyzed by measuring the mean
fluorescence intensity of 2′,7′-dichlorofluorescein using
a flow cytometer as described previously [14]. The datawere analyzed by FlowJo 7.6.1 software (Tree-Star, Ashland,
OR, USA). Three independent experiments were per-
formed. In each experiment, triplicate procedures were per-
formed for each group.
Cell proliferation assay
Cells were seeded into 96-well plates at 1 × 103 cells/
well and a volume of 100 μl. A CCK-8 Kit (Dojindo,
Kumamoto, Japan) was used to measure the cell prolif-
eration at 0, 2, 4, 6, and 8 days after seeding according
to the manufacturer’s recommendations. After incuba-
tion for 2 hours, the absorbance was measured at
450 nm by a Model 680 Microplate Reader (Bio-Rad,
Hercules, CA, USA). Three independent experiments
were performed. Each experiment was performed in
sextuplicate for each group.
Colony-forming unit fibroblast assay
Cells (1 × 103) were seeded into each well of a six-well
plate and incubated for 12 days in a humidified atmos-
phere (37°C, 5% carbon dioxide). Culture medium was
changed every 3 days. Subsequently, cultures were stained
with a Giemsa kit (Nanjing Jiancheng Bioengineering In-
stitute, Nanjing, China) according to the manufacturer’s
recommendations. Colonies with 50 or more cells in each
well of the six-well plate (n = 6 wells for each group) were
counted in the microscope. Twenty colonies in each group
were randomly selected for mean colony sizes and size
distribution analysis. The size of the colonies was mea-
sured by Image-J software [15]. Three independent experi-
ments were performed.
Scratch wound closure assay
We used the scratch wound assay to measure the migration
of the dermal derived cells as described previously [16]. In
brief, 5 × 105 cells/well were seeded into six-well plates and
cultured for 100% confluence, and then maintained for
another day in normal culture medium. A straight line
through the cell sheet was made by a p200 pipette tip. Each
well was washed with PBS to remove the cells debris and re-
placed with low serum (2%) culture medium for the cell
proliferation inhibition. Two markings created by a razor
blade on the outer bottom of each well were used as refer-
ence points close to the scratch. Images were captured at
the reference points every 12 hours until the wounds were
closed (100% confluent) with a microscope (Olympus,
Kyoto, Japan). The relative migration distances were mea-
sured by Image-J software. Three independent experi-
ments were performed. In each experiment, triplicate was
performed for each group.
Differentiation assay
For adipogenic differentiation, cells were seeded into six-
well plates with mouse mesenchymal stem cell adipogenic
Figure 1 Activation of dermal stem/progenitor cell proliferation after wounding. (A) At 3, 5, 7, 12, and 15 days after wounding, 5-bromo-2′-deoxyuridine
(BrdU) labels in the normal skin tissues or wounded tissues were detected by immunohistochemistry. The percentage of BrdU-positive cells was also
calculated, presented as mean ± standard deviation (C). C, control group (n= 3 per time point); d, days after wounding; L, long-term BrdU labeling group
(n= 3 per time point); S, a single BrdU labeling group (n= 3 per time point). Scale bar = 100 μm. (B) BrdU (100 mg/kg) was injected intraperitoneally for
three consecutive days (once per 12 hours) in nonwounded or wounded mice. Nonwounded dermal cells or granulation tissue-derived cells (GTCs) at
7 days post wounding were isolated and adherent cells were harvested for colony-forming assay. BrdU labels in the colonies were detected by
immunofluorescence. Scale bar = 500 μm. (D) Quantification of the colonies. CFU, colony-forming unit. **P< 0.01.
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China) according to the supplier’s instructions. After
3 weeks of differentiation, cells were washed with PBS and
then fixed in 10% formalin for 20 minutes and stained
with Oil-Red O (USA) solution for image acquisition. The
intracellular Oil-Red O was extracted with isopropyl alco-
hol for quantification. The absorbance of the extracted
Oil-Red O was measured at 490 nm using a Model 680
Microplate Reader (Bio-Rad). For osteogenic differenti-
ation, cells were seeded into 24-well plates with mouse
mesenchymal stem cell osteogenic differentiation medium
(Cyagen Biosciences) according to the supplier’s instruc-
tions. After 3 weeks of differentiation, cells were washed
with PBS and then fixed in 10% formalin for 20 minutes
and stained with Alizarin Red (Sigma) solution for image
acquisition. An osteogenesis assay kit (Millipore, Billerica,
MA, USA) was applied to quantify the Alizarin Red ac-
cording to supplier’s instructions.
Statistical analysis
Statistical analyses were performed using the SPSS 13.0
package (SPSS Inc., Chicago, IL, USA). Data were expressed
as mean ± standard deviation. An independent-samplesFigure 2 Stemness-related properties of granulation tissue-derived cells. Passage
used for experiments. (A) The proliferation ability of GTCs and nonwounded derm
of GTCs and nonwounded dermal cells. Results expressed as mean± standard de
in mouse mesenchymal stem cell adipogenic differentiation medium. After 22 da
quantified. (D) Osteogenic differentiation was performed in mouse mesenchyma
and stained by Alizarin Red. The Alizarin Red staining was also quantified. d, dayst test was used to determine the significant differences be-
tween two groups. Comparisons of multiple groups were
performed with one-way analysis of variance with correc-
tions for multiple comparisons. P <0.05 was considered sta-
tistically significant.
Results
Activation of dermal stem/progenitor cell proliferation
after wounding
It has been long accepted that LRCs represent the stem
cell populations in the skin [17], brain [18], bladder [19],
and so forth. Thus, we chose the BrdU pulse chase ap-
proach to identify the activated dermal stem/progenitor
cells in vivo. We treated the wounded mice with BrdU for
3 days after wounding. As shown in Figure 1A,C, BrdU-
positive cells decreased sharply during the healing process,
but were still found in the lower dermal part of the healed
wound bed (about 1.03 ± 0.11%). However, no transient-
amplifying cells after a single BrdU injection were detected
12 days after wounding (Figure 1A,C). In the nonwounded
dermis, no BrdU-positive LRCs or transient-amplifying cells
were found (Figure 1A). In addition, we stained the well-
known stem cell markers (Sox2, Oct4, CD133) in the2 granulation tissue-derived cells (GTCs) or nonwounded dermal cells were
al cells was detected every 2 days after seeding. (B) Colony-forming assay
viation (n= 6 wells per group). (C) Adipogenic differentiation was induced
ys, cells were fixed and stained by Oil-Red O. The Oil-Red O staining was also
l stem cell osteogenic differentiation medium. After 21 days, cells were fixed
; OD, optical density. **P <0.01. Scale bar = 500 μm.
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wounding, but no positive stained cells were found (data
not shown). Further, we isolated the BrdU-labeled GTCs to
test the LRCs in vitro. After 8 days of culture, the BrdU-
labeled GTCs could form colonies (20.66 ± 2.13; Figure 1D),
and BrdU-positive LRCs were also found in some colonies
(Figure 1B), while nonwounded dermal cells failed to form
colonies (Figure 1D). These results suggested that resident
dermal stem/progenitor cells were quiescent in non-
wounded dermis, and were activated after wounding.
Stemness-related properties of granulation tissue-derived
cells
Before isolating the GTCs, we measured the transient pro-
liferation of the granulation tissues by the 2 hours BrdUFigure 3 Therapeutic effects of granulation tissue-derived cells on combin
(GTCs), 1 × 106 per mouse in 0.2 ml phosphate-buffered saline (PBS), were i
combined skin wound injury. PBS (0.2 ml per mouse) served as control. (A)
residual rates of the GTC-treated group and the control group are presente
tissue depths were quantified in serial sections in the center of day 15 wou
presented as mean ± standard deviation (n = 6). (E) Representative photom
with PBS or GTCs. (F) Immunostaining for the classical myofibroblast-specif
derived from day 15 wounds injected with PBS or GTCs. Scale bars = 500 μpulse approach. The proliferation response of dermal tissues
initiated at 3 days after wounding reached a peak at 7 days
after wounding, and diminished at 15 days (Additional file
1). Thus, we chose to isolate GTCs at 7 days after wounding.
We then tested their stemness-related properties. GTCs
exhibited much higher proliferation capacity than non-
wounded dermal cells (Figure 2A). GTCs formed 43.33 ±
3.01 colonies after 12 days culture, while nonwounded cells
failed to form colonies (Figure 2B). In adipogenic differenti-
ation assay, GTCs produced more adipogenic phenotypic
cells stained by Oil-Red O, while nonwounded dermal cells
exhibited fewer phenotypic changes. Further, the optical
density level of Oil-Red O in induced GTCs (2.44 ± 0.07)
was significantly higher than in nonwounded dermal cells
(0.28 ± 0.02; Figure 2C). In osteogenic differentiationed radiation and skin wound injury. Granulation tissue-derived cells
njected around the skin wound margins post 6 Gy total body radiation
Representative wounds injected with PBS (control) or GTCs. (B) Wound
d as mean ± standard deviation (n = 6 mice per group). (C) The fibrotic
nds treated with PBS or GTCs. (D) Results of the fibrotic tissue depths
icrographs of Sirius Red-stained sections from day 15 wounds injected
ic marker alpha smooth muscle actin (α-SMA) of wound sections
m. d, days; DAPI, 4′,6-diamidino-2-phenylindole. **P <0.01, *P <0.05.
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strong staining of Alizarin Red (136.43 ± 7.82) than non-
wounded dermal cells (116.6 ± 3.36; Figure 2D). These re-
sults suggested that the proportion of adult dermal stem
cells in nonwounded dermis was very low. After wound-
ing, these cells were activated, enriched in granulation tis-
sues, and exhibited enhanced stemness-related properties.
Therapeutic effects of GTCs on combined radiation and
skin wound injury
It has been well documented that ionizing radiation can
delay the wound healing process [20]. In order to test the
therapeutic potential of GTCs, a combined radiation and
skin wound injury mouse model was further employed in
this study. Results showed that GTC transplantation signifi-
cantly accelerated wound closure (Figure 3A,B). In addition,
quantification of fibrotic tissue depth from day 15 (the time
of wounds healed) wounds confirmed a significant reduc-
tion in fibrotic tissue in GTC-treated wounds (333.34 ±
57.93 μm) compared with that in PBS-treated wounds
(443.21 ± 52.49 μm; Figure 3C,D). Moreover, Sirius Red
staining for fibrillar collagens revealed less collagen depos-
ition in GTC-treated wounds (Figure 3E). Further resultsFigure 4 miR-21 regulates the reactive oxygen species level of dermal-derive
dermal cells, granulation tissue-derived cells (GTCs), and GTCs pretreated with
real-time PCR. (B) Relative reactive oxygen species (ROS) levels of primary non
(50 nM) for 48 hours were detected by the ROS-sensitive dye 2′,7′-dichlorofluo
wild-type neonatal dermal cells, miR-21 knock-in neonatal dermal cells, and m
48 hours were detected by quantitative real-time PCR. (D) Relative ROS levels
dermal cells, and miR-21 knock-in neonatal dermal cells pretreated with miR-2
All results presented as mean ± standard deviation. d, days; DCF, 2′,7′-dichloro
wild-type, wild-type neonatal dermal cells. **P < 0.01.also showed that the myofibroblast marker α-smooth
muscle actin-positive cells were lower in the day 15 wounds
of GTC-treated wounds (Figure 3F). These data showed
that GTC transplantation could promote wound healing
and reduce tissue fibrosis in the combined radiation and
skin wound injury, suggesting the therapeutic implications
of GTCs in tissue replacement therapy.
miR-21 is a negative regulator of dermal-derived cells for
stemness-related properties
Our recent study has shown that miR-21 was upregu-
lated in granulation tissues after wounding by in situ
hybridization [11]. Here, we detected the miR-21 level
in GTCs and found it was significantly (29.8-fold
change) increased compared with nonwounded dermal
cells (Figure 4A). Thus, we further studied the roles of
miR-21 in the stemness-related properties of GTCs by
antagonizing miR-21 expression with miR-21 antago-
mir. Surprisingly, the miR-21 antagomir increased the
proliferation ability of GTCs (Figure 5A). Further, the
colony-forming unit fibroblast assay showed that miR-
21 antagomir-treated GTCs formed more colonies
(27 ± 1.26) compared with GTCs with control antagomird cells. (A) Relative microRNA (miR)-21 levels of primary nonwounded
N-acetylcysteine (NAC; 5 mM) for 48 hours were tested by quantitative
wounded dermal cells, GTCs, and GTCs pretreated with miR-21 antagomir
rescin diacetate (DCFH-DA; 10 mM). (C) Relative miR-21 levels of primary
iR-21 knock-in neonatal dermal cells pretreated with NAC (5 mM) for
of primary wild-type neonatal dermal cells, miR-21 knock-in neonatal
1 antagomir (50 nM) for 48 hours were measured by DCFH-DA (10 mM).
fluorescin; h, hours; miR-21 cells, miR-21 knock-in neonatal dermal cells;
Figure 5 miR-21 negatively regulates stemness-related properties of granulation tissue-derived cells. Passage 2 granulation tissue-derived cells (GTCs) were
pretreated with microRNA (miR)-21 antagomir (50 nM) or control antagomir (50 nM) for 48 hours. (A) The proliferation ability was detected by CCK-8 every
2 days after seeding. (B) Colony-forming assay of GTCs pretreated with miR-21 antagomir and control antagomir. Colonies presented as mean ± standard
deviation (n= 6 wells per group). Twenty colonies were randomly chosen in each group for analyzing (C) average colony sizes and (D) size distribution.
(E) Representative migration photographs of GTCs pretreated with miR-21 antagomir and control antagomir at indicated time points. (F) Relative migration
rate presented as mean ± standard deviation (n= 6 per time point for each group). (G) Adipogenic and (H) osteogenic differentiation of GTCs pretreated
with miR-21 antagomir or control antagomir were measured by staining with Oil-Red O and Alizarin Red and quantifying them respectively. CFU,
colony-forming units; d, days; h, hours; OD, optical density. *P< 0.05, **P< 0.01. Scale bar = 500 μm.
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Figure 6 miR-21 negatively regulates stemness-related properties of miR-21 knock-in neonatal dermal cells. Passage 2 microRNA (miR)-21 knock-in
neonatal dermal cells were pretreated with miR-21 antagomir or control antagomir (50 nM) for 48 hours, and wild-type neonatal dermal cells were treated
with control antagomir (50 nM) for 48 hours. (A) The proliferation ability of the three groups was detected every 2 days after seeding. Colony formation assay
including (B) colony numbers, (C) colony sizes, and (D) colony size distribution of the three groups was also measured. (E) Representative photographs of
migration of the three groups at indicated time points. (F) Relative migration rate of the three groups presented as mean ± standard deviation (n= 6 per time
point for each group). (G) Adipogenic and (H) osteogenic differentiation of the three groups were measured by staining with Oil-Red O and Alizarin Red and
quantifying them respectively. CFU, colony-forming units; d, days; h, hours; miR-21 cells, miR-21 knock-in neonatal dermal cells; wild-type, wild-type neonatal
dermal cells; OD, optical density. *P< 0.05, **P< 0.01. Scale bar = 500 μm.
Chen et al. Stem Cell Research & Therapy  (2015) 6:85 Page 10 of 15(20 ± 2.61; Figure 5B), and the sizes of the colonies were
also larger in miR-21 antagomir-treated GTCs (14.61 ±
2.25) compared with GTCs with control antagomir
(11.11 ± 2.75; Figure 5C,D). However, miR-21 antagomir
reduced migration of GTCs in a scratch wound closure
assay (Figure 5E,F), and the adipogenic and osteogenic dif-
ferentiation were also decreased in miR-21 antagomir-
treated GTCs (Figure 5G,H). These results suggested that
blockade of miR-21 could decrease the migration and
multidifferentiation of GTCs, but promote their prolifera-
tion and self-renewing capabilities.
To further confirm whether miR-21 negatively regulates
stemness-related properties of dermal derived cells, we
verified its effects on a miR-21 knock-in neonatal dermal
cell model. miR-21 knock-in neonatal dermal cells showed
decreased proliferation compared with wild-type neonatal
dermal cells (Figure 6A). In addition, they formed less col-
onies (12 ± 2.0) compared with wild-type neonatal dermal
cells (16.0 ± 3.97; Figure 6B). Moreover, the sizes of the
colonies of miR-21 knock-in neonatal dermal cells were
also smaller (Figure 6C,D). Further, miR-21 antagomir
could significantly reverse the decrease of the proliferation
and colony-forming abilities (Figure 6A,B,C,D). However,
miR-21 knock-in neonatal dermal cells showed increased
migration (Figure 6E,F) and adipogenic and osteogenic
differentiation (Figure 6G,H) compared with wild-type
neonatal dermal cells, and miR-21 antagomir could re-
verse that increase (Figure 6E,F,G,H). These results further
confirmed that miR-21 could decrease proliferation and
self-renewing capabilities, but could promote migration
and multidifferentiation of dermal-derived cells.
miR-21 negatively regulates the stemness-related proper-
ties of dermal-derived cells via a ROS-dependent pathway
Previous studies have shown that ROS were upregulated
at the wound site [21,22], but their functions in wound
healing are not fully identified. We measured the ROS
level in GTCs, and found it was significantly increased
in GTCs (261.55 ± 19.26) compared with nonwounded
dermal cells (100.00 ± 6.88; Figure 4B). To determine the
relationship between miR-21 and ROS, we antagonized
miR-21 expression in GTCs and found that the ROS
level decreased significantly (115.14 ± 7.91; Figure 4B).
On the other hand, we scavenged intracellular ROS inGTCs with a free radical scavenger (NAC), and the miR-
21 expression did not change significantly compared
with control GTCs (<0.5-fold change; Figure 4A). We
next verified the effect of miR-21 on ROS expression in
the miR-21 knock-in neonatal dermal cell model. As
shown in Figure 4D, the ROS level in miR-21 knock-in
neonatal dermal cells (122.96 ± 12.9) was increased com-
pared with wild-type cells (100 ± 2.12), and miR-21
antagomir reversed the increase. In addition, NAC also
did not affect miR-21 expression in miR-21 knock-in
neonatal dermal cells (<0.5-fold change; Figure 4C).
Further, to determine whether miR-21 regulates
stemness-related properties of dermal-derived cells
through a ROS-dependent pathway, we scavenged en-
dogenous ROS in the two miR-21 up-regulated cell pop-
ulations – GTCs and miR-21 knock-in neonatal dermal
cells with NAC – and tested their stemness-related
properties. As shown in Figure 7A, NAC-treated GTCs
exhibited increased proliferation ability compared to
control GTCs. In addition, the formed colonies (42 ± 2.45;
Figure 7B) and colony sizes (10.24 ± 2.89; Figure 7C, D)
of NAC-treated GTCs were increased compared with con-
trol GTCs (30.83 ± 9.15 and 7.68 ± 2.73, respectively).
However, the migration (Figure 7E,F) and adipogenic
(Figure 7G) and osteogenic (Figure 7H) differentiation
of NAC-treated GTCs were decreased compared with
control GTCs. Moreover, NAC-treated miR-21 knock-in
neonatal dermal cells also showed increased prolifera-
tion (Figure 8A) and formed more (Figure 8B) and
larger colonies (Figure 8C,D) compared with control
miR-21 knock-in neonatal dermal cells. Consistent with
GTCs, the migration (Figure 8E,F) and adipogenic
(Figure 8G) and osteogenic (Figure 8H) differentiation
of NAC-treated miR-21 knock-in neonatal dermal cells
were also decreased compared with control miR-21
knock-in neonatal dermal cells. All the above data sug-
gest that miR-21 could regulate stemness-related prop-
erties of dermal derived cells at least partially via a
ROS-dependent pathway.
Discussion
An ideal stem cell source should be easily accessible, im-
munologically compatible, capable to rapidly expand in
culture, and amenable to stable differentiation or
Figure 7 miR-21 negatively regulates stemness-related properties of granulation tissue-derived cells via a reactive oxygen species-dependent pathway.
N-acetyl cysteine (NAC; 5 mM) was added into culture medium and adipogenic and osteogenic induced medium of granulation tissue-derived cells (GTCs)
to scavenge the intracellular reactive oxygen species (ROS). (A) Proliferation of GTCs with and without NAC was measured every 2 days after seeding. Colony
formation assay including (B) colony numbers, (C) average colony sizes and (D) colony size distribution of GTCs with and without NAC was present. (E)
Representative migration photographs of GTCs with and without NAC at indicated time points. (F) The migration rate of the two groups presented as mean
± standard deviation (n= 6 per time point for each group). (G) The quantification and representative photographs of the Oil-Red O staining of the adipogenic
differentiation of GTCs with and without NAC. (H) Quantification and representative photographs of the Alizarin Red staining of the osteogenic differentiation
of GTCs and GTCs with NAC. CFU, colony-forming units; d, days; h, hours, OD, optical density. *P <0.05; **P <0.01. Scale bar = 500 μm.
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Figure 8 miR-21 negatively regulates stemness-related properties of miR-21 knock-in neonatal dermal cells via a reactive oxygen species
dependent pathway. N-acetyl cysteine (NAC; 5 mM) was added into culture medium and adipogenic and osteogenic induced medium of
miR-21 knock-in neonatal dermal cells to scavenge intracellular reactive oxygen species (ROS), and stemness related-properties of miR-21 knock-in
neonatal dermal cells with and without NAC were detected. (A) Proliferation was measured every 2 days after seeding. Colony formation assay
including (B) colony numbers, (C) average colony sizes, and (D) colony size distribution was present. (E) Representative migration photographs at
indicated time points. (F) Relative migration rate presented as mean ± standard deviation (n = 6 per time point for each group). (G) Quantification
and representative photographs of the Oil-Red O staining of the adipogenic differentiation. (H) Quantification and representative photographs
of the Alizarin Red staining of the osteogenic differentiation. CFU, colony-forming units; d, days; h, hours; miR-21 cells, miR-21 knock in neonatal
dermal cells; OD, optical density. **P <0.01. Scale bar = 500 μm.
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with easy accessibility, is a promising reservoir for adult
stem cells. In the epidermis, epidermal stem cells [23],
hair follicle stem cells, and melanocyte stem cells [6] are
resident. Recently, dermis has been proven to contain
stem cell populations [24-26]. However, the stem cell
proportion in the adult was relatively rare. Previous
studies demonstrated that the dermal stem cells de-
creased in number and capabilities of self-renewing or
proliferation with aging [8,27]. Skin frequently suffers
from injury, and the resident stem cells are proposed to
be activated for proliferation and differentiation by vari-
ous factors from the wound microenvironment including
cytokines, growth factors, and extracellular matrix com-
ponents released by platelets, leukocytes, and macro-
phages to fulfill the defects [28]. In this study, we
showed that dermal stem/progenitor cells were quies-
cent in nonwounded skin and were activated after wound-
ing and enriched in the granulation tissue. The isolated
GTCs exhibited enhanced proliferation, self-renewing, and
multidifferentiation capabilities compared with non-
wounded dermal cells. Very recently, studies have explored
the potential of granulation tissue-derived stem cells in the
tissue repair of liver and kidney [9,10], which further sug-
gests that granulation tissue is a promising source of adult
stem cells.
miRNAs are evaluated to regulate the expression of one-
third of genes, and their roles in wound healing have
already attracted much attention [29-32]. In a recent study,
we performed miRNA microarray profiling to estimate the
changes of the miRNAs at the stage of granulation forma-
tion during wound healing, and found that the expression
of at least 54 miRNAs changed significantly [11]. miR-21
was one of the most significantly upregulated miRNAs after
wounding, and the increased expression of miR-21 at the
wound sites was proposed to be modulated by inflamma-
tory factors especially transforming growth factor beta
[33,34]. Previous studies showed that the upregulated miR-
21 affected multiple aspects of the healing process by boot-
ing re-epithelialization [32], promoting migration of fibro-
blasts to the wound site [35], and enhancing collagen
deposition [11,36]. In this study, we continued to explore
the roles of miR-21 in GTCs. Data showed that miR-21 was
upregulated in GTCs. Blockade of miR-21 promotedproliferation and self-renewing of GTCs, but decreased
their migration and differentiation, which presented as a
negative modulator of the stemness-related properties. Pre-
vious studies demonstrated that miR-21 showed similar ef-
fects in stromal cells. It has been identified that miR-21
could decrease the proliferation of adipose tissue-derived
mesenchymal stem cells [37], but promote adipogenic dif-
ferentiation [38]. In condition with hypoxia and serum
deprivation, overexpression of miR-21 inhibited apoptosis
of mesenchymal stem cells [39]. However, miR-21 showed
different effects in epithelial cells. In a liver regeneration
model, miR-21 promoted hepatocyte proliferation by facili-
tating rapid cyclin D1 translation [40]. Another study
showed that miR-21 promoted the senescence of endothe-
lial progenitors by suppressing Hmga2 expression [41].
It is well established that ROS play important roles in
regulating cellular functions such as cell proliferation, migra-
tion, differentiation, apoptosis, and death [42-46]. According
to previous studies, the ROS level at the wound site was up-
regulated at the early stage of wound healing [22]. In this
study, the endogenous ROS level in GTCs was also in-
creased. Previously, ROS was shown to upregulate miR-
21expression via different pathways in different cell types
[47-53]. Interestingly, our data showed that scavenging en-
dogenous ROS did not decrease miR-21 expression. On the
contrary, inhibiting miR-21 expression suppressed the ROS
level significantly. In other studies, miR-21 was also shown
to regulate the endogenous ROS level. In the process of kid-
ney fibrogenesis, miR-21 upregulates ROS level by repres-
sing the mitochondrial inhibitor of ROS generation Mpv17l,
and enhances oxidative kidney damage [54]. miR-21 also tar-
gets superoxide dismutase 3 and tumor necrosis factor
alpha, and promotes tumorigenesis to a larger extent by
regulating endogenous ROS level [55]. Furthermore, we ex-
plored that scavenging endogenous ROS could mimic the
effects of miR-21 antagomir on GTC properties, which sug-
gested that miR-21 regulated their stemness-related proper-
ties at least partially via a ROS-dependent pathway.
Conclusions
The cell source is a keystone for stem cell-based therapy.
Previous studies have demonstrated that skin dermis is
an abundant stem cell source and is easily accessible.
However, stem cell numbers and plasticity deplete with
Chen et al. Stem Cell Research & Therapy  (2015) 6:85 Page 14 of 15aging. This study demonstrated that dermal stem/pro-
genitor cells were activated upon injury and enriched in
granulation tissue with enhanced stemness-related prop-
erties and therapeutic potential, and the miR-21/ROS
pathway negatively regulate stemness-related properties
of GTCs. Our results suggest that skin granulation tissue
represents a promising stem cell source for tissue repair
and regeneration.
Additional file
Additional file 1: Figure S1. Showing transient proliferation of skin
dermis after wounding. BrdU (100 mg/kg) was injected intraperitoneally
2 hours before the nonwounded and wound tissues sampling. Normal
skin tissues or wounded tissues (n = 3 per time point) at 1, 3, 5, 7, 9, 12,
15, and 20 days post wounding were harvested and fixed 48 hours in
4% paraformaldehyde and embedded in paraffin. Sections of 4 mm
were immunostained with BrdU antibody and color developed by
diaminobenzidine, and counterstained with hematoxylin. d, days after
wounding. Scale bar = 100 μm.
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